News

Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss potential in people with overweight or obesity was published in The Lancet and presented at the American Diabetes ...
Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss potential in people with overweight or obesity was published in The Lancet and presented at the American Diabetes ...
In a lump sum investment, investors invest the entire amount in one go, allowing their money to begin earning returns immediately. Let's find out how fast you can grow your Rs 6 lakh investment to Rs ...
Makaila Chenier, 17, found a lump in her neck. As it grew it became more difficult for her to breathe when she'd lie down. Doctors discovered it was lymphoma.
MONTREAL, May 27, 2025 /CNW/ - – Bristol Myers Squibb Canada (BMS) today announced that Health Canada has approved OPDIVO ® SC (nivolumab for subcutaneous injection) across all currently ...
Should you invest a lump sum amount at once, or should you opt for a Systematic Investment Plan (SIP)? Let's find out which is best for volatile market.
It is common for a man of Mr. Biden’s age to experience prostate issues. His spokesman declined to elaborate on any details about his care.
1 Department of Anesthesiology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China 2 Key Laboratory of Basic Research and Clinical Transformation of Perioperative Precision ...
Tayla Gardiner, 32, discovered a lump in her breast while she was in the shower. She credits her cup-E breast implants for helping her find the lump. She was diagnosed with triple-negative breast ...
Grade ≥ 3 drug-related adverse events (AEs) were reported in 47.0% of patients in the SC group and 47.6% in the IV group, with similar rates of discontinuations due to drug-related AEs (8.4% vs ...
In an interview with CURE®, Dr. Eric K. Singhi shared his insights into the primary advantages of utilizing the subcutaneous formulation of Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) compared ...